Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

NCT05621707 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinomas
Concurrent Chemoradiotherapy
Immunotherapy
Chemotherapy

Interventions

DRUG: chemotherapy combined with PD-1 inhibitors

Sponsor

Shanghai Chest Hospital